Second Indication Milestone Payments Sample Clauses

Second Indication Milestone Payments. Within *** following the first achievement of each milestone specified below by the Product for the second Indication to reach such milestone during the course of the Development of the Product, Licensee shall make the following respective milestone payment to Bayer: Milestone Payment Signature of an informed consent form by a patient in a Phase III Clinical Trial $ *** Submission of an NDA in the US $ *** Submission of an NDA Equivalent in the EU $ *** Submission of an NDA Equivalent in Japan $ *** Approval of NDA in the US $ *** Approval of NDA Equivalent in the EU $ *** Approval of NDA Equivalent in Japan $ ***